The experienced attorneys at Golomb & Honik represent
defective drug cases aggressively. If you have been injured by a defective, dangerous
drug, then you deserve compensation.
Last week, the US Food and Drug Administration told the manufacturers of
testosterone treatments that they must properly warn of the risk of blood
clots. Blood clots that form in the veins can be life-threatening if they
break free and travel to the lungs, which is known as a pulmonary embolism.
Previously, the FDA had warned of an increased risk of blood clots for
men who were taking testosterone treatments and also had a health condition
in which there was an unusual increase in red blood cell count. The new
warning issued by the FDA last week refers to a generalized risk of blood
clot without the existing health condition. The FDA began receiving many
reports of men suffering blood clots who did not have the red blood cell
condition and were taking testosterone treatments.
The agency says this new warning is unrelated to the investigation they
launched this past January. In that ongoing evaluation, the FDA is looking
into the possible link between testosterone treatment and the risk of
stroke, heart attack and death.
If you are searching for an experienced New Jersey or Philadelphia defective
drug attorney, please
contact Golomb & Honik for a free case evaluation.